I
Intellia Therapeutics
Cambridge, United States
Founded 2014 NASDAQ: NTLA
Gene Therapy Delivery Nano-Bio Cell Therapy Nano Protein Engineering Nanomedicine DNA Nanotechnology
About
CRISPR gene editing company using lipid nanoparticle delivery for in vivo therapeutics
Company Details
- Type
- public
- Employees
- 600+
- Funding
- Public
Key Products
- NTLA-2001
- CRISPR Platform